Figure 1From: A study protocol for the evaluation of occupational mutagenic/carcinogenic risks in subjects exposed to antineoplastic drugs: a multicentric project Occupational genotoxic risks in healthcare workers handling antineoplastic drugs: scheme of the study protocol. CP: cyclophosphamide; 8OHdG: 8-hydroxy-2'-deoxyguanosine; MN: micronuclei; CA: chromosome aberrations; GST: glutathione-S-transferase.Back to article page